PK

Prashant Kumar Pandey

Director DIN 07715464
DIN 07715464 First appointment Feb 2017
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Prashant Kumar Pandey

Data last updated:

Prashant Kumar Pandey was a Director at Nehsco Pharmaceuticals Private Limited (from 2018) and Managing Director at Ascura Healthcare Private Limited (from 2017).

DIN 07715464
First Appointment 08 Feb 2017
Oldest Company Age 10 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Oct 20182016Strike Off
Ascura Healthcare Private Limited U51909DL2017PTC312482
Managing Director08 Feb 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nehsco Pharmaceuticals Private Limited
Ascura Healthcare Private Limited
Premium access

Shareholding and investment profile for Prashant Kumar Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prashant Kumar Pandey

Prashant Kumar Pandey was first appointed on 08 Feb 2017 as Managing Director at Ascura Healthcare Private Limited. The most recent appointment on record is 04 Oct 2018 at Nehsco Pharmaceuticals Private Limited.

Prashant Kumar Pandey held 2 earlier board appointments: Nehsco Pharmaceuticals Private Limited (Director, from 04 Oct 2018); Ascura Healthcare Private Limited (Managing Director, from 08 Feb 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available